< Back to companies

Jieyi Biotech, headquartered in Hangzhou, Zhejiang, is an innovative technology company focusing on molecular diagnosis of infectious diseases. We are committed to integrating and innovating cutting-edge technologies such as genetic testing, big data analysis and artificial intelligence, and using leading diagnostic technology to promote changes in the diagnosis and treatment of infectious diseases, making disease diagnosis simpler, faster and smarter. Focusing on the two cutting-edge technology platforms of high-throughput sequencing (NGS) and gene editing (CRISPR/Cas), the company has laid out a number of independently developed core technology patents and built multi-level, high-quality products in the field of molecular diagnosis of infectious diseases. line and service system to provide clinical patients with overall solutions for molecular diagnosis of infectious diseases.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2019
Website
www.matridx.com/

Categories

Infectious DiseaseMolecular DiagnosticsBiotechClinical Diagnostics
Only accessible to MedStartr community members. Join now

What do you think of Matridx (杰毅生物)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now